Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$21,672,529
+$1,688,826 QoQ
Shares Held
85,335
+4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#712
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Foster Victor Wealth Advisors, LLC holds $146,000,046 across 9 Drug Manufacturers - General names. JNJ ranks #4 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
93,625 | $23,559,795 | |
| 2 | AMGN |
Amgen Inc
|
64,695 | $23,427,353 | |
| 3 | GSK |
GSK plc
|
414,286 | $21,716,872 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
85,335 | $21,672,529 | |
| 5 | PFE |
Pfizer Inc
|
819,225 | $19,726,938 | |
| 6 | LLY |
ELI LILLY & Co
|
15,754 | $18,895,821 | |
| 7 | MRK |
Merck & Co., Inc.
|
122,130 | $15,693,705 | |
| 8 | AZN |
Astrazeneca PLC
|
3,899 | $739,328 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,672,529 | 85,335 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $19,983,703 | 81,753 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $18,590,318 | 89,830 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $16,818,706 | 90,706 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $13,397,549 | 87,709 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $14,024,093 | 84,564 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $11,824,998 | 81,766 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $11,658,434 | 71,939 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $15,635,612 | 106,976 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $15,435,863 | 97,578 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $14,138,261 | 90,202 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $13,742,134 | 88,232 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $16,140,848 | 97,516 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $14,209,005 | 91,671 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $14,735,083 | 83,414 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $12,953,794 | 79,296 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $12,768,649 | 71,932 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $11,886,993 | 67,071 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $9,905,124 | 57,901 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $8,400,099 | 52,013 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $8,035,522 | 48,777 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $7,209,870 | 43,869 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $6,136,875 | 38,994 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,050,307 | 33,922 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,440,532 | 31,576 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $3,588,372 | 27,365 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||